🔗 Permalink

Inventor profile of:

Jan Poolman

City:

Rixensart

Country:

Belgium

Published Applications:

Last publication date:

2020-06-11

Top Assignees for applications by Jan Poolman

The entities that hold a legal rights for patent applications filed by inventor Poolman Jan:

GlaxoSmithKline Biologicals S.A. 42 Rixensart, Belgium
University of Utrecht 3 Utrecht, Netherlands
UTRECHT UNIVERSITY 2 Utrecht, Netherlands
GlaxoSmithKline Biologicals SA 1 , Belgium
GLAXOSMITHKLINE SA 1 Rixensart, Belgium
The Brigham & Women's Hospital, Inc. 1 Boston, MA United States
GlaxoSmithKline 1 King of Prussia, PA United States
Glaxo Smith Kline Biologicals S.A. 1 Rixensart, Belgium
GlaxoSmithKline Biologicals s. a. 1 Rixensart, Belgium
GLAXOSMITHKLINE BIOLOGIECALS, S.A. 1 Rixensart, Belgium
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION 1 Columbus, OH United States

Recent patent applications by Poolman Jan

Jan Poolman from Rixensart, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-06-11

US20200179504A1

Human necessities

IMMUNOGENIC COMPOSITION FOR USE IN VACCINATION AGAINST STAPHYLOCOCCI

#2 | 2020-01-02

US20200000911A1

Human necessities

IMMUNOGENIC COMPOSITION

#3 | 2019-10-03

US20190298822A1

Human necessities

Immunogenic composition

#4 | 2019-03-14

US20190076516A1

Human necessities

Immunogenic composition for use in vaccination against staphylococci

#5 | 2019-01-10

US20190008943A1

Human necessities

VACCINE

#6 | 2018-04-19

US20180104323A1

Human necessities

IMMUNOGENIC COMPOSITION

#7 | 2018-03-08

US20180064806A1

Human necessities

Immunogenic composition

#8 | 2017-07-27

US20170209562A1

Human necessities

IMMUNOGENIC COMPOSITION

#9 | 2017-03-23

US20170080075A1

Human necessities

VACCINE

#10 | 2017-03-09

US20170065714A1

Human necessities

Immunogenic composition

#11 | 2016-08-25

US20160243211A1

Human necessities

VACCINE COMPRISING PROTEIN NMB0964 FROM NEISSERIA MENINGITIDIS

#12 | 2016-06-23

US20160175423A1

Human necessities

VACCINE COMPOSITION

#13 | 2016-03-24

US20160082097A1

Human necessities

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

#14 | 2015-11-19

US20150328302A1

Human necessities

IMMUNOGENIC COMPOSITION FOR USE IN VACCINATION AGAINST STAPHYLOCOCCEI

#15 | 2015-05-07

US20150125481A1

Human necessities

Immunogenic Composition

#16 | 2015-02-12

US20150044253A1

Human necessities

Immunogenic composition

#17 | 2014-10-02

US20140294935A1

Human necessities

VACCINE COMPOSITION

#18 | 2014-04-10

US20140099339A1

Human necessities

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

#19 | 2013-07-04

US20130171188A1

Human necessities

Immunogenic composition

#20 | 2013-02-21

US20130045231A1

Human necessities

Immunogenic composition

#21 | 2013-01-10

US20130011429A1

Human necessities

IMMUNOGENIC COMPOSITION

#22 | 2013-01-03

US20130004530A1

Human necessities

VACCINE COMPOSITION

#23 | 2013-01-03

US20130004510A1

Human necessities

Vaccine

#24 | 2012-12-20

US20120321658A1

Human necessities

IMMUNOGENIC COMPOSITION COMPRISING S. PNEUMONIAE POLYSACCHARIDES CONJUGATED TO CARRIER PROTEINS

#25 | 2012-08-16

US20120207780A1

Human necessities

Vaccine composition

#26 | 2012-07-26

US20120189654A1

Human necessities

VACCINE

#27 | 2012-03-15

US20120064120A1

Human necessities

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

#28 | 2012-03-15

US20120064119A1

Human necessities

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

#29 | 2012-02-16

US20120039942A1

Chemistry; metallurgy

Outer membrane vesicles and uses thereof

#30 | 2012-02-02

US20120027800A1

Human necessities

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

#31 | 2011-09-08

US20110217329A1

Human necessities

Vaccine

#32 | 2011-09-01

US20110212124A1

Human necessities

Vaccine Composition

#33 | 2011-08-04

US20110189215A1

Human necessities

Vaccine comprising protein NMB0964 from

#34 | 2011-07-07

US20110165590A1

Physics

Vaccine protection assay

#35 | 2011-02-10

US20110033500A1

Human necessities

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis

#36 | 2011-01-13

US20110008419A1

Human necessities

Vaccine Against Streptococcus Pneumoniae

#37 | 2011-01-13

US20110008385A1

Human necessities

Immunogenic composition

#38 | 2010-12-23

US20100322959A1

Human necessities

Immunogenic composition

#39 | 2010-11-18

US20100291138A1

Human necessities

Vaccine

#40 | 2010-11-18

US20100291137A1

Human necessities

METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN

#41 | 2010-11-11

US20100285465A1

Chemistry; metallurgy

Molecular Typing of Neisseria Strains by Determining the Presence of Genes Involved in Lipooligosaccharide (LOS) Biosynthesis

#42 | 2010-09-23

US20100239604A1

Human necessities

Vaccine comprising capsular polysaccharide conjugates

#43 | 2010-08-19

US20100209450A1

Human necessities

Vaccine comprising capsular polysaccharide conjugates

#44 | 2010-07-22

US20100183662A1

Human necessities

VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

#45 | 2010-05-13

US20100119544A1

Human necessities

Vaccine

#46 | 2010-03-25

US20100074922A1

Human necessities

Pneumococcal polysaccharide conjugate vaccine

#47 | 2010-03-25

US20100074918A1

Human necessities

VACCINE

#48 | 2010-02-25

US20100047287A1

Chemistry; metallurgy

Outer membrane vesicles and uses thereof

#49 | 2010-01-28

US20100021503A1

Human necessities

IMMUNOGENIC COMPOSITION

#50 | 2009-10-08

US20090252759A1

Human necessities

Immunogenic composition

#51 | 2009-07-09

US20090175912A1

Chemistry; metallurgy

outer membrane protein and use thereof in vaccination

#52 | 2009-06-25

US20090162394A1

Human necessities

VACCINE

#53 | 2009-06-18

US20090155887A1

Chemistry; metallurgy

Vaccine Composition

#54 | 2009-05-28

US20090136541A1

Human necessities

Immunogenic composition

#55 | 2009-05-14

US20090123499A1

Human necessities

VACCINE

#56 | 2009-05-07

US20090117147A1

Human necessities

VACCINES COMPRISING OUTER MEMBRANE VESICLES FROM GRAM NEGATIVE BACTERIA

#57 | 2009-02-12

US20090041802A1

Human necessities

Immunogenic composition

#58 | 2009-01-15

US20090017072A1

Human necessities

Vaccine

#59 | 2009-01-15

US20090017059A1

Human necessities

Vaccine Comprising Streptococcus Pneumoniae Capsular Polysaccharide Conjugates

#60 | 2009-01-08

US20090010959A1

Human necessities

Pneumococcal Polysaccharide Conjugate Vaccine

#61 | 2008-12-18

US20080311146A1

Human necessities

Immunogenic Composition

#62 | 2008-12-11

US20080305127A1

Human necessities

Conjugate Vaccines

#63 | 2008-09-25

US20080233154A1

Human necessities

Vaccine Composition

#64 | 2008-09-11

US20080220457A1

Physics

Serum bactericidal assay for specific antisera

#65 | 2008-08-21

US20080199490A1

Human necessities

Immunogenic composition

#66 | 2008-08-14

US20080193476A1

Human necessities

Immunogenic composition

#67 | 2008-04-24

US20080095777A1

Human necessities

Immunogenic Composition for Use in Vaccination Against Staphylococcei

#68 | 2008-04-10

US20080085289A1

Human necessities

Immunogenic Composition

#69 | 2008-04-03

US20080081050A1

Human necessities

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

#70 | 2008-03-20

US20080069835A1

Human necessities

VACCINE COMPOSITION

#71 | 2008-03-13

US20080064057A1

Physics

Vaccine protection assay

#72 | 2008-01-31

US20080025993A1

Human necessities

Method for Refolding Neisserial Nspa Protein

#73 | 2007-05-24

US20070116711A1

Human necessities

Pertussis antigens and use thereof in vaccination

#74 | 2007-02-08

US20070031449A1

Chemistry; metallurgy

Outer membrane vesicles and uses thereof

#75 | 2006-11-09

US20060251671A1

Chemistry; metallurgy

Haemophilus influenza outer membrane protein and use thereof in vaccination

#76 | 2006-10-26

US20060240045A1

Human necessities

Neisserial vaccine compositions comprising a combination of antigens

#77 | 2006-09-28

US20060216307A1

Human necessities

Vaccine composition

#78 | 2006-09-14

US20060204520A1

Chemistry; metallurgy

Vaccine composition

#79 | 2006-05-04

US20060093626A1

Human necessities

Vaccine

#80 | 2006-03-09

US20060051379A1

Human necessities

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-

#81 | 2006-03-09

US20060051361A1

Human necessities

Vaccine against Streptococcus pneumoniae

#82 | 2006-02-16

US20060034854A1

Human necessities

Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria

#83 | 2006-01-05

US20060002961A1

Human necessities

Vaccine

#84 | 2005-12-22

US20050281847A1

Chemistry; metallurgy

Vaccine composition

#85 | 2005-09-29

US20050214329A1

Human necessities

Vaccine

#86 | 2005-02-10

US20050031646A1

Human necessities

Vaccine

InventorID:

10665 ⎘